Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.uca.edu.ar/handle/123456789/8705
Campo DC Valor Lengua/Idioma
dc.contributor.authorSachdeva, Robines
dc.contributor.authorSchlotterer, Andreaes
dc.contributor.authorSchumacher, Dagmares
dc.contributor.authorMatka, Christines
dc.contributor.authorMathar, Ilkaes
dc.contributor.authorDietrich, Nadinees
dc.contributor.authorMedert, Rebekkaes
dc.contributor.authorKriebs, Ulriches
dc.contributor.authorLin, Jihonges
dc.contributor.authorNawroth, Peteres
dc.contributor.authorBirnbaumer, Lutzes
dc.contributor.authorFleming, Thomases
dc.contributor.authorFreichel, Marces
dc.contributor.authorHammes, Hans Peteres
dc.date.accessioned2019-09-09T22:10:35Z-
dc.date.available2019-09-09T22:10:35Z-
dc.date.issued2018-
dc.identifier.citationSachdeva R, Schlotterer A, Schumacher D, et al. TRPC proteins contribute to development of diabetic retinopathy and regulate glyoxalase 1 activity and methylglyoxal accumulation [en línea]. Molecular Metabolism. 2018;9:156-167. doi:10.1016/j.molmet.2018.01.003 Disponible en:es
dc.identifier.issn2212-8778-
dc.identifier.urihttps://repositorio.uca.edu.ar/handle/123456789/8705-
dc.description.abstractObjective Diabetic retinopathy (DR) is induced by an accumulation of reactive metabolites such as ROS, RNS, and RCS species, which were reported to modulate the activity of cation channels of the TRPC family. In this study, we use Trpc1/4/5/6−/− compound knockout mice to analyze the contribution of these TRPC proteins to diabetic retinopathy. Methods We used Nanostring- and qPCR-based analysis to determine mRNA levels of TRPC channels in control and diabetic retinae and retinal cell types. Chronic hyperglycemia was induced by Streptozotocin (STZ) treatment. To assess the development of diabetic retinopathy, vasoregression, pericyte loss, and thickness of individual retinal layers were analyzed. Plasma and cellular methylglyoxal (MG) levels, as well as Glyoxalase 1 (GLO1) enzyme activity and protein expression, were measured in WT and Trpc1/4/5/6−/− cells or tissues. MG-evoked toxicity in cells of both genotypes was compared by MTT assay. Results: We find that Trpc1/4/5/6−/− mice are protected from hyperglycemia-evoked vasoregression determined by the formation of acellular capillaries and pericyte drop-out. In addition, Trpc1/4/5/6−/− mice are resistant to the STZ-induced reduction in retinal layer thickness. The RCS metabolite methylglyoxal, which represents a key mediator for the development of diabetic retinopathy, was significantly reduced in plasma and red blood cells (RBCs) of STZ-treated Trpc1/4/5/6−/− mice compared to controls. GLO1 is the major MG detoxifying enzyme, and its activity and protein expression were significantly elevated in Trpc1/4/5/6-deficient cells, which led to significantly increased resistance to MG toxicity. GLO1 activity was also increased in retinal extracts from Trpc1/4/5/6−/− mice. The TRPCs investigated here are expressed at different levels in endothelial and glial cells of the retina. Conclusion The protective phenotype in diabetic retinopathy observed in Trpc1/4/5/6−/− mice is suggestive of a predominant action of TRPCs in Müller cells and microglia because of their central position in the retention of a proper homoeostasis of the neurovascular unit.es
dc.language.isoenges
dc.publisherElsevieres
dc.rightsAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.sourceMolecular Metabolism. 2018;9:156-167es
dc.subjectRETINOPATIA DIABETICAes
dc.subjectENFERMEDADES METABOLICASes
dc.subjectHIPERGLUCEMIAes
dc.titleTRPC proteins contribute to development of diabetic retinopathy and regulate glyoxalase 1 activity and methylglyoxal accumulationes
dc.typeArtículoes
dc.identifier.doi10.1016/j.molmet.2018.01.003-
dc.identifier.pmid29373286-
uca.issnrd1es
uca.affiliationFil: Sachdeva, Robin. Heidelberg Universit. Institute of Pharmacology; Alemaniaes
uca.affiliationFil: Schlotterer, Andrea. Heidelberg Universit. Medical Faculty Mannheim. Vth Department of Medicine; Alemaniaes
uca.affiliationFil: Schumacher, Dagmar. Heidelberg Universit. Institute of Pharmacology; Alemaniaes
uca.affiliationFil: Matka, Christin. Heidelberg Universit. Institute of Pharmacology; Alemaniaes
uca.affiliationFil: Mathar, Ilka. Heidelberg Universit. Institute of Pharmacology; Alemaniaes
uca.affiliationFil: Dietrich, Nadine. Heidelberg Universit. Medical Faculty Mannheim. Vth Department of Medicine; Alemaniaes
uca.affiliationFil: Medert, Rebekka. Heidelberg Universit. Institute of Pharmacology; Alemaniaes
uca.affiliationFil: Kriebs, Ulrich. Heidelberg Universit. Institute of Pharmacology; Alemaniaes
uca.affiliationFil: Lin, Jihong. Heidelberg Universit. Medical Faculty Mannheim. Vth Department of Medicine; Alemaniaes
uca.affiliationFil: Nawroth, Peter. University Hospital Heidelberg. Department of Medicine I and Clinical Chemistry; Alemaniaes
uca.affiliationFil: Nawroth, Peter. German Center for Diabetes Research; Alemaniaes
uca.affiliationFil: Nawroth, Peter. Institute for Diabetes and Cancer IDC Helmholtz Center Munich; Alemaniaes
uca.affiliationFil: Nawroth, Peter. eidelberg University Hospital. Departament of Medicine I. Joint Heidelberg Institute for Diabetes and Cancer Translational Diabetes Program; Alemaniaes
uca.affiliationFil: Birnbaumer, Lutz. National Institute of Environmental Health Sciences. Neurobiology Laboratoy; Estados Unidoses
uca.affiliationFil: Birnbaumer, Lutz. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Instituto de Investigaciones Biomédicas; Argentinaes
uca.affiliationFil: Hammes, Hans-Peter. Heidelberg Universit. Medical Faculty Mannheim. Vth Department of Medicine; Alemaniaes
uca.affiliationFil: Freichel, Marc. Heidelberg Universit. Institute of Pharmacology; Alemaniaes
uca.versionpublishedVersiones
item.grantfulltextopen-
item.fulltextWith Fulltext-
item.languageiso639-1en-
crisitem.author.deptInstituto de Investigaciones Biomédicas - BIOMED-
crisitem.author.deptLaboratorio de Función y Farmacología de Canales Iónicos-
crisitem.author.deptConsejo Nacional de Investigaciones Científicas y Técnicas-
crisitem.author.deptFacultad de Ciencias Médicas-
crisitem.author.orcid0000-0002-0775-8661-
crisitem.author.parentorgFacultad de Ciencias Médicas-
crisitem.author.parentorgInstituto de Investigaciones Biomédicas - BIOMED-
crisitem.author.parentorgPontificia Universidad Católica Argentina-
Aparece en las colecciones: Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
trpc-proteins-contribute-development.pdf2,18 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem

Visualizaciones de página(s)

129
comprobado en 27-abr-2024

Descarga(s)

159
comprobado en 27-abr-2024

Google ScholarTM

Ver en Google Scholar


Altmetric

Altmetric


Este ítem está sujeto a una Licencia Creative Commons Creative Commons